PL2188306T3 - Fragmenty powstałe po cięciu immunoglobuliny jako wskaźniki choroby oraz kompozycje do ich wykrywania i wiązania - Google Patents
Fragmenty powstałe po cięciu immunoglobuliny jako wskaźniki choroby oraz kompozycje do ich wykrywania i wiązaniaInfo
- Publication number
- PL2188306T3 PL2188306T3 PL08782610T PL08782610T PL2188306T3 PL 2188306 T3 PL2188306 T3 PL 2188306T3 PL 08782610 T PL08782610 T PL 08782610T PL 08782610 T PL08782610 T PL 08782610T PL 2188306 T3 PL2188306 T3 PL 2188306T3
- Authority
- PL
- Poland
- Prior art keywords
- binding
- compositions
- detecting
- cleavage fragments
- disease indicators
- Prior art date
Links
- 108060003951 Immunoglobulin Proteins 0.000 title 1
- 238000003776 cleavage reaction Methods 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000012634 fragment Substances 0.000 title 1
- 102000018358 immunoglobulin Human genes 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000007017 scission Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/734—Complement-dependent cytotoxicity [CDC]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Physical Education & Sports Medicine (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95516207P | 2007-08-10 | 2007-08-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2188306T3 true PL2188306T3 (pl) | 2017-01-31 |
Family
ID=40351057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08782610T PL2188306T3 (pl) | 2007-08-10 | 2008-08-04 | Fragmenty powstałe po cięciu immunoglobuliny jako wskaźniki choroby oraz kompozycje do ich wykrywania i wiązania |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20090155280A1 (pl) |
| EP (1) | EP2188306B1 (pl) |
| JP (2) | JP5530356B2 (pl) |
| KR (2) | KR101588276B1 (pl) |
| CN (2) | CN101889021B (pl) |
| AU (1) | AU2008287128B2 (pl) |
| BR (1) | BRPI0814355A2 (pl) |
| CA (1) | CA2696011A1 (pl) |
| DK (1) | DK2188306T3 (pl) |
| EA (1) | EA025220B1 (pl) |
| ES (1) | ES2593791T3 (pl) |
| HU (1) | HUE029649T2 (pl) |
| IL (1) | IL203544A (pl) |
| MX (1) | MX2010001616A (pl) |
| NZ (1) | NZ582916A (pl) |
| PL (1) | PL2188306T3 (pl) |
| PT (1) | PT2188306T (pl) |
| SG (1) | SG183701A1 (pl) |
| WO (1) | WO2009023457A1 (pl) |
| ZA (1) | ZA201001689B (pl) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8501907B2 (en) | 2007-08-10 | 2013-08-06 | Janssen Biotech, Inc. | Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such |
| ES2788457T3 (es) | 2009-10-23 | 2020-10-21 | Millennium Pharm Inc | Moléculas de anticuerpo anti-GCC y composiciones y métodos relacionados |
| EA201290241A1 (ru) | 2009-10-29 | 2013-02-28 | Янссен Байотек Инк. | Изменение гликозилирования антител |
| US8041225B2 (en) * | 2009-12-21 | 2011-10-18 | General Electric Company | Contactless infrared data transmission for wind turbines |
| WO2012067624A1 (en) * | 2010-11-19 | 2012-05-24 | Yxcentocor Ortho Biotech Inc. | Immunoglobulin cleavage fragments vaccine compositions |
| KR101820558B1 (ko) | 2010-12-23 | 2018-02-28 | 유리타 아. 게. | 넓은 영역에 나노 구조체를 생산하기 위한 시스템 및 방법 |
| NZ612379A (en) * | 2010-12-23 | 2014-10-31 | Janssen Biotech Inc | Active protease-resistant antibody fc mutants |
| SA113340502B1 (ar) * | 2012-04-27 | 2015-09-17 | ميلينيوم فارماسيوتيكالز، انك | جزيئات أجسام مضادة لـ gcc وطرق لاستخدام هذه الجزيئات |
| DK3729958T3 (da) | 2013-03-15 | 2023-08-07 | Mayo Found Medical Education & Res | Identificering og overvågning af monoklonale immunoglobuliner ved hjælp af molekylmasse |
| TWI715524B (zh) * | 2013-12-27 | 2021-01-11 | 日商中外製藥股份有限公司 | 等電點低之抗體的精製方法 |
| CA2944767C (en) | 2014-04-04 | 2022-07-12 | Mayo Foundation For Medical Education And Research | Isotyping immunoglobulins using accurate molecular mass |
| WO2017053932A1 (en) | 2015-09-24 | 2017-03-30 | Mayo Foundation For Medical Education And Research | Identification of immunoglobulin free light chains by mass spectrometry |
| AU2017325022B2 (en) * | 2016-09-07 | 2022-10-13 | Mayo Foundation For Medical Education And Research | Identification and monitoring of cleaved immunoglobulins by molecular mass |
| EP3681907A4 (en) | 2017-09-13 | 2021-07-07 | Mayo Foundation for Medical Education and Research | IDENTIFICATION AND MONITORING OF IMMUNOGLOBULIN J-CHAINS |
| US11946937B2 (en) | 2017-09-13 | 2024-04-02 | Mayo Foundation For Medical Education And Research | Identification and monitoring of apoptosis inhibitor of macrophage |
| EP3720884A4 (en) | 2017-12-07 | 2021-09-29 | Chugai Seiyaku Kabushiki Kaisha | ANTIBODIES, COMPOSITIONS FOR USE IN THE DETECTION OR DETERMINATION OF A POLYPEPTIDE IN A SAMPLE, AND METHODS OF DETECTING OR DETERMINING A POLYPEPTIDE IN A SAMPLE |
| US20210325380A1 (en) * | 2020-04-20 | 2021-10-21 | EnLiSense, LLC | Disease diagnostics using a multi-configurable sensing array |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6796094A (en) * | 1993-04-29 | 1994-11-21 | Raymond Hamers | Production of antibodies or (functionalized) fragments thereof derived from heavy chain immunoglobulins of (camelidae) |
| AUPM322393A0 (en) * | 1993-12-24 | 1994-01-27 | Austin Research Institute, The | Mucin carbohydrate compounds and their use in immunotherapy |
| US7129331B2 (en) * | 2000-05-31 | 2006-10-31 | Pestka Biomedical Laboratories, Inc. | Phosphorylated polypeptides and uses related thereto |
| GB0130228D0 (en) * | 2001-12-18 | 2002-02-06 | Hansa Medica Ab | Protein |
-
2008
- 2008-08-04 ES ES08782610.3T patent/ES2593791T3/es active Active
- 2008-08-04 BR BRPI0814355-2A2A patent/BRPI0814355A2/pt not_active IP Right Cessation
- 2008-08-04 KR KR1020107005265A patent/KR101588276B1/ko not_active Expired - Fee Related
- 2008-08-04 EP EP08782610.3A patent/EP2188306B1/en not_active Not-in-force
- 2008-08-04 SG SG2012058665A patent/SG183701A1/en unknown
- 2008-08-04 MX MX2010001616A patent/MX2010001616A/es active IP Right Grant
- 2008-08-04 CN CN200880102840.1A patent/CN101889021B/zh not_active Expired - Fee Related
- 2008-08-04 CA CA2696011A patent/CA2696011A1/en not_active Abandoned
- 2008-08-04 KR KR1020157013122A patent/KR20150059813A/ko not_active Ceased
- 2008-08-04 HU HUE08782610A patent/HUE029649T2/en unknown
- 2008-08-04 CN CN201310054803.0A patent/CN103497254B/zh not_active Expired - Fee Related
- 2008-08-04 NZ NZ582916A patent/NZ582916A/xx not_active IP Right Cessation
- 2008-08-04 DK DK08782610.3T patent/DK2188306T3/en active
- 2008-08-04 PL PL08782610T patent/PL2188306T3/pl unknown
- 2008-08-04 AU AU2008287128A patent/AU2008287128B2/en not_active Ceased
- 2008-08-04 JP JP2010520241A patent/JP5530356B2/ja not_active Expired - Fee Related
- 2008-08-04 US US12/185,333 patent/US20090155280A1/en not_active Abandoned
- 2008-08-04 WO PCT/US2008/072083 patent/WO2009023457A1/en not_active Ceased
- 2008-08-04 PT PT87826103T patent/PT2188306T/pt unknown
- 2008-08-04 EA EA201070236A patent/EA025220B1/ru not_active IP Right Cessation
-
2010
- 2010-01-27 IL IL203544A patent/IL203544A/en not_active IP Right Cessation
- 2010-03-09 ZA ZA2010/01689A patent/ZA201001689B/en unknown
-
2013
- 2013-10-30 JP JP2013225205A patent/JP2014058535A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2014058535A (ja) | 2014-04-03 |
| EA201070236A1 (ru) | 2010-08-30 |
| AU2008287128B2 (en) | 2013-07-18 |
| KR20100059850A (ko) | 2010-06-04 |
| AU2008287128A1 (en) | 2009-02-19 |
| US20090155280A1 (en) | 2009-06-18 |
| WO2009023457A1 (en) | 2009-02-19 |
| CN103497254A (zh) | 2014-01-08 |
| CA2696011A1 (en) | 2009-02-19 |
| MX2010001616A (es) | 2010-03-15 |
| EP2188306A4 (en) | 2011-03-02 |
| EP2188306B1 (en) | 2016-06-29 |
| CN103497254B (zh) | 2016-12-28 |
| SG183701A1 (en) | 2012-09-27 |
| PT2188306T (pt) | 2016-09-13 |
| DK2188306T3 (en) | 2016-08-22 |
| JP5530356B2 (ja) | 2014-06-25 |
| EP2188306A1 (en) | 2010-05-26 |
| KR20150059813A (ko) | 2015-06-02 |
| ES2593791T3 (es) | 2016-12-13 |
| KR101588276B1 (ko) | 2016-01-26 |
| BRPI0814355A2 (pt) | 2015-01-27 |
| HUE029649T2 (en) | 2017-02-28 |
| JP2010536037A (ja) | 2010-11-25 |
| CN101889021A (zh) | 2010-11-17 |
| IL203544A (en) | 2015-07-30 |
| EA025220B1 (ru) | 2016-12-30 |
| NZ582916A (en) | 2012-08-31 |
| ZA201001689B (en) | 2011-06-29 |
| CN101889021B (zh) | 2016-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201001689B (en) | Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such | |
| GB2464430B (en) | Emulsified composition | |
| EP2185201A4 (en) | COMPOSITIONS AND METHODS FOR CRYSTALLIZING ANTIBODIES | |
| PL2061346T3 (pl) | Kompozycja spożywcza zmniejszająca uczulenie na alergen | |
| ZA201000983B (en) | Methods and compositions for diagnosing disease | |
| IL236237A (en) | Tmem154 antibodies and their segments and uses | |
| ZA200807960B (en) | Catalyst composition | |
| GB0713232D0 (en) | Staple remover | |
| GB0719065D0 (en) | coalescing materials | |
| EP2068819A4 (en) | Dendrimer COMPOSITIONS | |
| ZA200903656B (en) | Novel composition | |
| EP2278984A4 (en) | COMPOSITIONS AND METHODS FOR ENHANCING FERTILITY | |
| EP1997013A4 (en) | IDENTIFICATION OF MODIFICATIONS TO CONTENTS OF MEDIA DEVICES | |
| IL208188A0 (en) | Compositions comprising antibodies or antibody fragments | |
| EP2034019A4 (en) | COMPOSITION FOR THE NUCLEENIC ACID INTRODUCTION | |
| PL386709A1 (pl) | Kompozycja oczyszczająca | |
| GB2450822B (en) | Sample preparation | |
| HK1142915A (en) | Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such | |
| GB0621329D0 (en) | Novel composition | |
| GB0622341D0 (en) | Novel compounds and methods for their preparation | |
| GB0621279D0 (en) | Binding site | |
| AU3501P (en) | Sentinel 3R Triticum aestivum | |
| HK1150427A (en) | Compositions and methods for crystallizing antibody fragments | |
| GB0723044D0 (en) | Lyophillised antigen composition | |
| GB0723900D0 (en) | Lyophillised antigen composition |